In this episode of the Palo Alto Networks podcast 'Threat Vector,' host David Molton speaks with Jim Foote, CEO of First Ascent Biomedical about his transition from Chief Information Security Officer (CISO) to leading a biotech company utilizing AI to personalize cancer treatments. They discuss how Foote's personal experience with his son's cancer diagnosis drove him to apply cybersecurity principles in developing an innovative approach, called Functional Precision Medicine, which tailors cancer treatment to individual patients. The conversation also covers the role of mentorship, the importance of interdisciplinary skills, and the transformative potential of AI in both cybersecurity and medical fields.

Join the conversation on our social media channels:

• 
  Website: ⁠⁠⁠⁠https://www.paloaltonetworks.com/unit42⁠⁠⁠⁠
  


• 
  Threat Research: ⁠⁠⁠⁠https://unit42.paloaltonetworks.com/⁠⁠⁠⁠
  


• 
  Facebook: ⁠⁠⁠⁠https://www.facebook.com/LifeatPaloAltoNetworks/⁠⁠⁠⁠
  


• 
  LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/company/unit42/⁠⁠⁠⁠
  


• 
  YouTube: ⁠⁠⁠⁠@PaloAltoNetworksUnit42⁠⁠⁠⁠
  


• 
  Twitter: ⁠⁠⁠⁠https://twitter.com/PaloAltoNtwks⁠⁠⁠⁠
  

About Threat Vector

Unit 42 Threat Vector is the compass in the world of cyberthreats. Hear about Unit 42’s unique threat intelligence insights, new threat actor TTPs, real-world case studies, and learn how the team works together to discover these threats. Unit 42 will equip listeners with the knowledge and insight to proactively prepare and stay ahead in the ever-evolving threat landscape.

Palo Alto Networks

Palo Alto Networks enables your team to prevent successful cyberattacks with an automated approach that delivers consistent security across the cloud, network, and mobile. ⁠http://paloaltonetworks.com⁠